Last reviewed · How we verify

NCT05423574: r-TARUP

Robotic Trans-Abdominal Retromuscular Umbilical Prosthesis (r-TARUP)

Completed Last updated 21 June 2022
What this trial tests

trial testing robotic Trans Abdomino Pre Peritoneal prothesis repair in Ventral Hernia in 20 participants. Completed in 1 March 2022.

Timeline
1 January 2021
Primary endpoint
1 July 2021
1 March 2022

Quick facts

Lead sponsorCentral Hospital, Nancy, France
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date1 January 2021
Primary completion1 July 2021
Estimated completion1 March 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Central Hospital, Nancy, France

Who can join

18 and older, any sex, with Ventral Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Combining the advantage of minimally invasive surgery with laparoscopy to reduce postoperative complications and the placement of a retromuscular prosthesis with closure of the defect in order to reduce the risk of adhesion and restore normal anatomy in the treatment of primary and incisional ventral hernias, is made possible through robotic assistance. The challenge of this study concerns the evaluation of quality of life, postoperative pain and recurrence at 6 months in the management of primary and incisional ventral hernias by robot-assisted laparoscopic approach.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ventral Hernia

Currently open trials in the same condition.

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05423574.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing